The new tool injects real-time budget awareness into agent reasoning loops, tackling runaway compute and tool calls.

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

(L-R) Harrison Query and Jeremy Saulnier (inset); Joel Edgerton Chelsea Fisher / Juan Veloz / Michael Buckner EXCLUSIVE: In a bidding war, Netflix has nabbed Trigger Point starring Joel Edgerton ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

President Donald Trump on Friday signed the Homebuyers Privacy Protection Act (H.R. 2808), establishing a nationwide ban on the abusive use of trigger leads beginning ...

While most PC players opt for keyboard and mouse, some like to use a controller. Those that choose a PlayStation 5 controller are often looking for ways to turn off the Adaptive Triggers of the ...